Bagsværd, Denmark, 9 February 2017 - Novo Nordisk A/S has filed its Annual Report 2016 on Form 20-F for the financial year 2016 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2016. The reports are available at the SEC's website, www.sec.gov, as well as on novonordisk.com.
Shareholders and ADR holders may receive a hard copy of the annual reports free of charge upon request by filling out a request form on novonordisk.com or upon request to email@example.com - please state the exact mailing address and the document(s) you wish to receive.
Read the press release
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire